 |
three human IgG1 mAbs (REGN3470, REGN3471, and REGN3479) directed against different epitopes on Ebola virus glycoprotein |
|---|---|
| Trade Name | |
| Orphan Indication | Ebola |
| USA Market Approval | USA |
| USA Designation Date | 2016-07-14 00:00:00 |
| Sponsor | Regeneron Pharmaceuticals, Inc.;777 Old Saw Mill River Road;Tarrytown, New York, 10591 |
